Henry Schein, Inc. (NASDAQ:HSIC) COO Michael S. Ettinger Sells 12,240 Shares

Henry Schein, Inc. (NASDAQ:HSIC) COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Henry Schein Stock Down 1.5 %

Henry Schein stock opened at $73.73 on Thursday. The firm has a 50 day moving average price of $70.68 and a two-hundred day moving average price of $69.69. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The firm has a market cap of $9.19 billion, a price-to-earnings ratio of 30.34, a PEG ratio of 2.15 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the previous year, the business earned $1.32 earnings per share. Henry Schein’s revenue for the quarter was up .4% on a year-over-year basis. Equities analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current year.

Institutional Investors Weigh In On Henry Schein

Several large investors have recently added to or reduced their stakes in the business. Virtu Financial LLC acquired a new position in Henry Schein in the third quarter valued at approximately $239,000. TCW Group Inc. lifted its position in shares of Henry Schein by 6.6% during the 3rd quarter. TCW Group Inc. now owns 26,368 shares of the company’s stock valued at $1,922,000 after acquiring an additional 1,628 shares during the period. Toronto Dominion Bank boosted its stake in Henry Schein by 68.3% during the third quarter. Toronto Dominion Bank now owns 62,779 shares of the company’s stock worth $4,577,000 after acquiring an additional 25,474 shares in the last quarter. M&T Bank Corp grew its holdings in Henry Schein by 4.5% in the third quarter. M&T Bank Corp now owns 10,990 shares of the company’s stock worth $802,000 after purchasing an additional 472 shares during the period. Finally, Barclays PLC grew its holdings in Henry Schein by 6.9% in the third quarter. Barclays PLC now owns 286,475 shares of the company’s stock worth $20,882,000 after purchasing an additional 18,458 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

HSIC has been the topic of a number of recent analyst reports. Evercore ISI lifted their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Robert W. Baird lowered their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Barrington Research restated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. JPMorgan Chase & Co. decreased their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Finally, UBS Group dropped their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $78.89.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.